HMGB1-Dependent Triggering of HIV-1 Replication and Persistence in Dendritic Cells as a Consequence of NK-DC Cross-Talk by Saïdi, Héla et al.
HMGB1-Dependent Triggering of HIV-1 Replication and
Persistence in Dendritic Cells as a Consequence of NK-DC
Cross-Talk
He ´la Saı ¨di, Marie-The ´re `se Melki, Marie-Lise Gougeon*
Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, INSERM U668, Paris, France
Abstract
Background: HIV-1 has evolved ways to exploit DCs, thereby facilitating viral dissemination and allowing evasion of antiviral
immunity. Recently, the fate of DCs has been found to be extremely dependent on the interaction with autologous NK cells,
but the mechanisms by which NK-DC interaction controls viral infections remain unclear. Here, we investigate the impact of
NK-DC cross-talk on maturation and functions of HIV-infected immature DCs.
Methodology/Principal Findings: Immature DCs were derived from primary monocytes, cultured in the presence of IL-4
and GM-CSF. In some experiments, DCs were infected with R5-HIV-1BaL or X4-HIV-1NDK, and viral replication, proviral HIV-
DNA and the frequency of infected DCs were measured. Autologous NK cells were sorted and either kept unstimulated in
the presence of suboptimal concentration of IL-2, or activated by a combination of PHA and IL-2. The impact of 24 h NK-DC
cross-talk on the fate of HIV-1-infected DCs was analyzed. We report that activated NK cells were required for the induction
of maturation of DCs, whether uninfected or HIV-1-infected, and this process involved HMGB1. However, the cross-talk
between HIV-1-infected DCs and activated NK cells was functionally defective, as demonstrated by the strong impairment of
DCs to induce Th1 polarization of naı ¨ve CD4 T cells. This was associated with the defective production of IL-12 and IL-18 by
infected DCs. Moreover, the crosstalk between activated NK cells and HIV-infected DCs resulted in a dramatic increase in
viral replication and proviral DNA expression in DCs. HMGB1, produced both by NK cells and DCs, was found to play a
pivotal role in this process, and inhibition of HMGB1 activity by glycyrrhizin, known to bind specifically to HMGB1, or
blocking anti-HMGB1 antibodies, abrogated NK-dependent HIV-1 replication in DCs.
Conclusion: These observations provide evidence for the crucial role of NK-DC cross-talk in promoting viral dissemination,
and challenge the question of the in vivo involvement of HMGB1 in the triggering of HIV-1 replication and replenishment of
viral reservoirs in AIDS.
Citation: Saı ¨di H, Melki M-T, Gougeon M-L (2008) HMGB1-Dependent Triggering of HIV-1 Replication and Persistence in Dendritic Cells as a Consequence of NK-
DC Cross-Talk. PLoS ONE 3(10): e3601. doi:10.1371/journal.pone.0003601
Editor: Derya Unutmaz, New York University School of Medicine, United States of America
Received August 14, 2008; Accepted October 9, 2008; Published October 31, 2008
Copyright:  2008 Saı ¨di et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by Institutional grant from Institut Pasteur. HS was supported by a postdoctoral fellowship from Sidaction, and MTM by a
PhD grant from the Ministe `re de la Recherche.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mlgougeo@pasteur.fr
Introduction
Early stages of HIV-1 infection are associated with local
recruitment and activation of important effectors of innate
immunity, NK cells and DCs. In the first hours and days of
mucosal infection, HIV-1 crosses the epithelial barrier and infects
CCR5-expressing DCs, macrophages and T cells in the mucosal
tissues to initiate infection [1,2]. DCs express CD4, CCR5, DC-
SIGN [3] and other C-type lectin receptors (CLRs) that facilitate
capture and dissemination of HIV-1 [4,5]. Immature DCs (iDCs)
capture HIV-1 through CLRs [6] and captured virus can be
internalized and rapidly transmitted to nearby CD4 T cells, in the
form of an infectious synapse [7,8]. DC-T cell conjugates facilitate
productive infection in CD4 T cells [9], and dissemination of the
infection to the draining lymph nodes and subsequent other
lymphoid tissue compartments is ensured by virus-carrying DCs
together with infected macrophages and CD4 T cells [10].
Migration of iDC to T cell area of secondary lymphoid tissues
after virus uptake is associated to a maturation process, that allows
the resulting mature DC (mDC) to prime an antigen-specific
response [11]. Recently, the fate of DCs has been found to be
extremely dependent on autologous NK cells [12]. NK-iDC
interaction results in activation of NK cells that, in turn, induces
DC maturation or killing, depending on their respective density [13–
15].DCundergoingmaturationsecreteseveralcytokines,suchasIL-
12 and IL-18, that act as potent inducers of NK cell activation and
cytotoxicity [16–20]. In turn, once activated, NK cells produce IFN-
c and TNF-a, capable of inducing DC maturation. This
phenomenon is dependent on the engagement of NKp30 by ligands
expressed oniDC[17,21],andthedown-regulationoniDCofHLA-
E, the ligand for CD94/NKG2A inhibitory receptor [22]. Another
mechanism was proposed suggesting that NK cells, activated by IL-
18 released by iDC at the synaptic cleft, secrete HMGB1, which
inducesDCmaturationandprotectsDCsfromlysis[20].HMGB1is
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functions to stabilize nucleosome formation, and acts as a
transcription-factor-like protein that regulates the expression of
several genes [23,24]. HMGB1 is released from necrotic cells, but it
can also be secreted by activated macrophages [25] and activated
NKcells [20] inresponsetoinflammatorystimuli,and it isoneofthe
main prototypes of the damage-associated molecular pattern
molecules (DAMPs) [26]. It was recently discovered to be a crucial
cytokine in the immune system, facilitating the trafficking of
inflammatory leukocytes, and being critical for DCs to mature,
reach the lymph nodes and sustain the proliferation of antigen-
specificT cells,and to promote theirpolarization towardsa T-helper
1 phenotype [27,28].
The mechanisms involved in NK-DC interaction during viral
infections are poorly understood. It was recently reported in
murine CMV (MCMV) infection that MCMV-infected DCs were
capable of activating syngeneic NK cells in vitro and also capable of
enhancing NK-cell dependent clearance in vivo [29], demonstrating
the crucial role of NK-DC cross-talk in controlling viral replication.
In HIV infection, NK-DC interaction was found defective in HIV-
1-infected viremic, but not aviremic patients, characterized by
abnormalities in the process of reciprocal NK-DC activation and
maturation, as well as a defect in NK-cell elimination of iDCs [30].
We investigated the role of NK-DC cross-talk on maturation,
function, and susceptibility to viral replication of HIV-1-infected
iDCs. We discovered that maturation of HIV-1-infected DCs could
be triggered by activated NK cells, but it was associated with a
strong impairment of mature infected DCs to induce Th1
polarization following their cross-talk with NK cells. In addition,
the cross-talk between NK cells and HIV-1-infected iDCs resulted
in a dramatic increase in viral replication and proviral DNA
expression in DCs. This process was mainly triggered by HMGB1,
released both by NK cells and DCs, as a consequence of NK-DC
cross-talk. This study provides new insights into how HIV ‘hijacks’
DCs to promote efficiently viral dissemination.
Results
Activated NK cells induce the maturation of autologous
primary immature dendritic cells infected with HIV-1
To investigate the role of NK cells on DC maturation, we
generated monocyte-derived DCs from isolated monocytes and
cocultured them with NK cells purified from the same donor. NK
cells were either resting (rNK) or activated by a combination of PHA
and IL-2 (aNK). 24 h of coculture of aNK cells with autologous
immatureDC(iDC)inducedeitherthesurvivalorapoptosisofiDCs,
dependent on NK-DC ratio, consistent with previous reports [14].
Indeed, aNK-DC ratio of 5:1 induced DC apoptosis, while 1:5 ratio
induced DC survival. (Fig. 1a). iDCs survival at a NK-DC ratio of
1:5 was associated with their maturation, as shown by the increased
coexpression of the maturation markers CD86 and HLA-DR
(72.1% of CD86
brightHLA-DR
bright DCs were induced by aNK cells
compared to 15.3% at baseline) (Fig. 1b), a feature of mature DCs.
Under the same experimental conditions, rNK cells had a weaker
effect on DC maturation, as judged by the proportion of
CD86
brightHLA-DR
bright DCs (Fig. 1b,e). Following infection of
iDC with HIV-1BaL, NK-dependent maturation of iDCs was not
altered (Fig. 1b), under conditions of productive infection of iDCs,
measured at day 3 by p24 release in culture supernatant and
intracellular staining of iDC for p24 (Fig. 1c). Investigating the
direct effect of HIV-1 on DC maturation, we found that, at
concentrations ranging from 0.001 to 10 ng/ml, HIV-1BaL was
unable to increase the expression of the maturation markers CD86
and HLA-DR, in contrast to LPS, used as a positive control as a
strong inducer of DC maturation (Fig. 1b,d). Data from three
representative donors, shown in Fig. 1e, confirm the high impact of
aNK cells on maturation of iDC after 24 h of coculture, whatever
the infected or uninfected status of iDC. These experiments have all
been reproduced with X4-HIV-1 and very similar data were
obtained (data not shown). From these data, we conclude that
productively HIV-1-infected iDCs have maintained a normal
susceptibility to maturation induced by NK cells during the NK-
DC cross-talk.
aNK-DC cross-talk triggers HMGB1 expression in both NK
cells and DCs
In order to identify the molecules involved in aNK-dependent
maturation of iDC, we used multianalyte profiling (MAP)to map the
key cytokines produced in 24 h culture of iDC, NK cells and
aNK:iDC. iDC released low amounts of IL-1ß, IL-6 and IL-12, and
theydidnotproduceIL-10orTNF-a.Followingtheircoculturewith
aNK cells, a proinflammatory cytokine profile was induced, with a
highincreaseinIL-12secretion,significantlevelsofTNF-aandIFN-
c, bothderived fromNK cells,and no production of IL-10 (Fig.2a).
Interestingly, high levels of HMGB1 were detected in those culture
supernatants, originating both from iDC and NK cells, and
aNK:iDC cocultures resulted in a strong enhancement of HMGB1
concentration inculturesupernatants(Fig.2a).Weconfirmed atthe
single cell level, by confocal microscopy, that NK cells were able to
produceHMGB1,detectedinthenucleusoffreshlyisolatedNKcells
(Fig. 2b), and further translocated to the cytoplasm in aNK cells
(Fig. 2c). Following 3 h incubation with HIV-1BaL, aNK cells
showed a strong decrease in HMGB1 expression, detected both in
culture supernatants and by confocal microscopy (Fig. 2c), possibly
due to a direct inhibitory effect of HIV virions on NK cell functions
through the binding of gp120 [31]. HMGB1 level reached then a
level comparable to that ofrNK cells (Fig.2a).WecheckedthatNK
cells were not able to replicate HIV-1, as shown by the lack of p24
detection in culture supernatant and the lack of intracellular p24
staining (detected by FACS) in NK cells (data not shown). HMGB1
was also secreted by iDCs and, once infected, they still produced
comparableamountofthecytokineinculturesupernatants(Fig.2d).
HMGB1 was mostly detected in the cytoplasm of iDCs, whether
infected by HIV-1 or not (Fig. 2e), and p24 expression in infected
DCsdidnotalterHMGB1expression,asshownbydualintracellular
stainingforp24andHMGB1(Fig.2e).WheniDCswerecocultured
with aNK cells, a strong induction of HMGB1 secretion in culture
supernatants was observed (Fig. 2d), reaching levels comparable to
those produced by mature DCs, i.e. DC0, DC1 and DC2 (Fig. 2f).
Strikingly, HIV-1 infection of iDC did not affect the amount of
HMGB1 produced in NK-DC cocultures (Fig. 2d) and in cultures
of mature DCs (Fig. 2f). Confocal microscopy analysis showed the
formation of conjugates between aNK cells and iDCs, which were
also observed when aNK cells were cocultured with HIV-1-infected
DCs, and both cells expressed HMGB1, whatever the infected status
of DCs (Fig. 2g). These results demonstrate that HMGB1 is
expressed both by NK cells and iDCs during NK-DC cross-talk, and
this process is not altered by HIV-1 infection of iDCs.
aNK-dependent maturation of HIV-1-infected iDCs is
mediated by HMGB1 and involves RAGE
To determine the possible involvement of HMGB1 in NK-
dependent DC maturation, we used glycyrrhizin, known to
interact specifically with soluble HMGB1 molecule [32], and
anti-HMGB1 antibodies (Fig. 3a). These inhibitors, added at the
initiation of the 24 h aNK-iDC coculture, reduced the proportions
of mature DCs (identified as CD86
brightHLA-DR
bright) to the
NK-DC Crosstalk and HIV
PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3601Figure 1. aNK cells induce the maturation of primary immature HIV-1-infected DCs. (a) iDCs, generated from purified CD14
+ monocytes in
the presence of IL-4 and GM-CSF, were cocultured during 24 h with aNK cells at different ratios. DC survival was determined by flow cytometry with
the 7-AAD assay. Surviving DCs were identified as 7AAD
2 CD56
2 cells. Data represent three independent experiments and values are means6sd. (b)
aNK cells induce the maturation of iDCs. Flow cytometry analysis of iDCs, which were either infected with HIV-1BaL (1 ng/ml of p24) for 3 h or
uninfected, were incubated with rNK cells or aNK cells at a ratio of 1:5. Co-staining with HLA-DR and CD86 specific antibodies allowed the
identification of mature DCs (CD86
brightHLA-DR
bright). Data from a representative experiment out of three independent experiments are shown. (c)
The conditions of infection used in this study were those of a productive infection of iDCs, as shown at day 3 by a significant p24 detection in culture
supernatant of infected iDCs and intracellular detection by flow cytometry of p24 in DC targeted by CD40 expression. Experiments were performed
NK-DC Crosstalk and HIV
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was obtained with infected DCs (Fig. 3a). rh-HMGB1 by itself did
not induce phenotypic maturation of iDC, when treated for 24 h
with 1 to 10 mg/ml rh-HMGB1, and similar data were obtained at
48 h of culture (Fig. 3b). Indeed, while spontaneous maturation of
iDCs was observed after 48 h of culture in medium, as shown by
the high percentage of CD86
bright HLA-DR
bright DCs, 10 mg/ml
rh-HMGB1 only weakly increased from 65% to 71% the
percentage of these cells. Interestingly, rh-HMGB1-treated DCs
were not fully mature, as assessed by the lack of expression of
CD80, CD83 and the weak expression of DC-lamp, all fully
expressed in mDC (DC0) (Fig. 3b). However, these partially
mature DCs were functionally susceptible to rh-HMGB1 as shown
by the increased release of the chemokines, MCP1, MIP-1a, MIP-
1b and IL-8 by hr-HMGB1-treated DCs (Fig. 3c). HMGB1
receptors include RAGE [33,34] TLR-2 and TLR-4 [35]. RAGE
was the first identified receptor for HMGB1, it is expressed by a
variety of immune cells including T cells, monocytes, macrophages
and DCs [36], and it is used by maturing DCs for in vivo homing to
lymph nodes [37]. While TLR-2 and TLR-4 were hardly detected
on iDC (not shown), RAGE was fully expressed on DCs, as shown
by flow-cytometry, and its expression was even higher on mature
DC0 (Fig. 3d). Following incubation of iDCs with 1 mg/ml of
HMGB1, down-regulation of RAGE was observed, strongly
suggesting that this receptor was used by these cells (Fig. 3d).
Following DC infection with HIV-1BaL, no change in RAGE levels
was detected on iDC and DC0. Incubation of infected DCs with
HMGB1 induced similar down-regulation of RAGE (Fig. 3d).
The possible involvement of RAGE during NK-DC cross-talk was
evaluated with the same approach, comparing RAGE expression
on DCs cocultured with aNK cells and DC cultured alone. After
2 h of coculture with aNK cells, DCs showed an up-regulation of
RAGE expression, followed by a down-regulation at 24 h
(Fig. 3e). Very similar observations were made with HIV-1-
infected DCs (Fig. 3e). Thus, HMGB1 is an important factor for
the maturation of both uninfected and HIV-1-infected iDCs
during NK-DC cross talk, and it involves RAGE, whose
expression on iDC is not altered following their productive
infection.
Impairment of Th1 polarization by HIV-infected DCs as a
consequence of a defective NK-DC cross-talk
It has been shown that the interaction of NK cells with iDCs
results in the induction of type-1 polarized DCs that serve as
carriers of the NK cell-derived help for the induction of Th1
responses [38]. To assess the capacity of DCs, whether infected or
uninfected, to polarize a Th1 response following their cross-talk
with aNK cells, naı ¨ve CD4
+CD45RO
2 T cells were cocultured for
8 days in the presence of DCs and aNK cells, and Th1
polarization was determined by the detection in T cells of the
intracellular production of IFN-c and IL-4, measured by FACS
(Fig. 4a). Coculture of naı ¨ve T cells with iDCs did not increase
the proportion of IFN-c positive T cells, and similar data were
obtained in coculture of naı ¨ve T cells with iDCs and rNK cells. In
contrast, cocultures of naı ¨ve T cells with iDC in the presence of
aNK cells induced a significant increase of IFN-c T cell response
(Fig. 4b), suggesting that aNK:iDC cross-talk is essential for Th1
polarization. When the same experiment was performed with
HIV-1BaL-infected DC, no Th1 polarization was observed
(Fig. 4c). The contribution of HIV-1 replication to the inhibition
of Th1 polarization was shown by the addition of AZT, which
restored the increased IFN-c T cell response induced by infected
DCs cocultured with aNK cells (Fig. 4d). We used AZT at a
concentration inhibiting viral replication in these conditions, as
assessed by the dosage of p24 antigen in the supernatants (data not
shown). IL-12 and IL-18 are critical cytokines produced by DCs
and involved in Th1 polarization. We therefore addressed the
question of the impact of aNK-DC cross-talk on the release of
these cytokines by DCs. We found that aNK-DC cross talk triggers
both IL-12 and IL-18 secretion by non infected DCs. Importantly,
the production of both cytokines was not detected anymore in
cocultures of aNK cells and infected DCs (Fig. 4e, f). In addition,
the triggering of IFN-c production by NK cells during aNK-DC
cross talk was not detected anymore when the coculture was
performed with HIV-1 infected DC (Fig. 4g). Thus, the priming
of DCs for Th1 polarization occurs during aNK-iDC cross-talk,
though the induction of cytokines such as IL-12 and IL-18 released
by DCs, and IFN-c released by NK cells. Following their infection
with HIV-1, iDCs cannot be polarized anymore by aNK cells, due
to a defective NK-DC cross-talk. Consequently HIV-1 infected
DCs are impaired in their capacity to induce Th1 polarization.
Pivotal role of HMGB1 in NK-DC dependent triggering of
HIV-1 replication and persistence in iDCs
Since we showed that the impairment of Th1 polarization by
NK-sensitized HIV-1-infected DCs was dependent on HIV-1
replication (Fig. 4d), we tested whether aNK-iDC interaction
could trigger HIV-1 replication in DCs. iDCs were infected for 3 h
with R5- or X4-HIV-1 (1 ng/ml of p24) and further cultured
either alone or in the presence of rNK or aNK for 18 h, and the
frequency of DCs with intracellular expression of p24 was
determined by flow cytometry. While the percentage of p24
+
DCs was quite low when HIV-infected iDCs were cultured alone,
it significantly increased following their interaction with aNK cells,
the p24
+ DCs representing almost one third of all DCs as
compared to only 4% in the absence of NK cells (Fig. 5a). Under
the same conditions, rNK cells had no effect on HIV replication in
iDCs (Fig. 5a). aNK-dependent increased HIV replication in
infected DCs was confirmed by p24 antigen detection in culture
supernatants, and a statistically significant increase of p24
production was detected in cocultures of aNK with HIV-1-iDC
as compared to infected iDCs cultured alone or with rNK cells
(Fig. 5b). The dramatic effect of NK-DC interaction on the
frequency of p24-expressing DCs was confirmed by confocal
microscopy with p24-specific antibodies. While very rare DCs
were stained for intracellular p24 on the day following their
infection, a high number of p24
+ DC were observed after their
culture with aNK cells (Fig. 5c). Interestingly, the positive
influence of aNK cells on HIV replication in iDCs was similarly
observed on mature DCs. An increased frequency of p24
+ DCs,
detected by FACS, was found in HIV-1-infected DC0 cocultured
during 24 h with aNK cells as compared to DC0 cultured alone
on DCs from three independent donors, and values are means6sd. (d) HIV-1 infection does not induce by itself the maturation of iDC, as shown by
CD86/HLA-DR dual staining of iDCs infected with 0.001 to 10 ng/ml p24 HIV-1BaL. The proportion of mDCs induced by LPS (DC0) (78.1%
CD86
brightHLA-DR
bright) is shown as a positive control. (e) The proportion of mature CD86
brightHLA-DR
bright DCs induced in the indicated cocultures of
infected or uninfected iDCs with either rNK or aNK cells are shown. These experiments have been performed on primary cells from a number of
donors, and representative data from three of them are shown. When indicated, statistical analyses were made with the non-parametric Mann-
Whitney test. * p,0.05, ** p=0.02.
doi:10.1371/journal.pone.0003601.g001
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PLoS ONE | www.plosone.org 4 October 2008 | Volume 3 | Issue 10 | e3601Figure 2. aNK-DC cross-talk triggers HMGB1 expression in both aNK cells and DCs. (a) 24 h cell-free culture supernatants of iDCs, rNK
cells, aNK cells (10
6/ml), or cocultures of aNK cells and iDCs (ratio 1:5) were tested for cytokine content. MAP technology was used to quantify IL-1b,
IL-6, IL-10, TNF-a, IL-12 and IFN-c, whereas HMGB1 was quantified by ELISA. * p,0.05 (non-parametric Mann-Whitney test). (b) HMGB1 expression
was detected by immunofluorescence (in red) in freshly sorted blood NK cells. Counterstaining with DAPI (in blue) showed the nuclear localisation of
HMGB1. (c) Incubation of aNK cells with HIV-1 inhibits HMGB1 secretion. Left panel: aNK cells (10
6 cells/ml) were incubated in medium or with
HIV-1BaL (1 ng/ml of p24) for 3 h and tested for HMGB1 production 21 h later. Data represent three independent experiments and values are
means6sd. Right panel: immunofluorescence analysis of HMGB1 expression in the same preparations of aNK cells. (d) HMGB1 production during
aNK-iDC cross-talk is not inhibited by HIV-1 infection of iDCs. iDCs were incubated for 3 h in medium or with HIV-1BaL (1 ng/ml of p24) and further
NK-DC Crosstalk and HIV
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infected mature DC0, DC1 and DC2 cocultured with aNK cells,
confirmed the significant stimulating effect of aNK cells on HIV-1
replication in mature DCs. This was observed whether DCs were
infected with X4- or R5-HIV-1) (Fig. 5f and 5g). Of note, rNK
cells had a weak impact on HIV-1 replication in mature infected-
DCs (Fig. 5f and 5g). We then tested whether aNK cells had an
influence on the expression of proviral DNA in iDCs. Data in
Figure 5e show that a very high increase in the number of HIV-1
proviral DNA copies was detected in cultures of infected iDCs with
aNK cells, as compared with that of infected iDCs with rNK cells
or infected iDCs alone.
Exogenous HMGB1 was recently reported to increase HIV-1
replication in infected monocytic cell lines [39], and to induce in
vitro the reactivation of HIV-1 in PBMCs from HIV-1-infected
patients under antiretroviral therapy [40]. Therefore, we ad-
dressed the question of the role of HMGB1 in the NK-dependent
triggering of HIV replication in DCs. We found that exogenous
rh-HMGB1 had a direct effect on HIV-1BaL-infected iDC,
enhancing dramatically the production of p24 in culture
supernatants (Fig. 6a). rh-HMGB1 had also a significant
stimulatory effect on p24 production by HIV-1-infected iDC
cocultured with a NK cells (Fig. 6a). To investigate the influence
of HMGB1 in the triggering of HIV-1 replication in infected-iDC-
aNK cocultures, HMGB1-specific neutralizing antibodies or
glycyrrhizin were added to these cocultures and p24 production
was measured in the supernatant. Both HMGB1 inhibitors
abrogated HIV-1 production by infected DC cocultured with
aNK cells or cultured alone (Fig. 6b). These results indicate that
exogenous HMGB1 is able to trigger HIV-1 replication by
infected iDC. They also indicate that aNK cell-dependent
stimulation of HIV-1 replication in iDCs is mediated by HMGB1.
Discussion
Although direct infection of DCs is less efficient than infection of
CD4
+ T cells [41,42] an increasing amount of evidence indicates
that long-term HIV transmission that is mediated by DCs depends
on viral production by the DCs [43–45], and HIV-infected DCs in
vivo might function as viral reservoirs during migration to the
lymphoid tissues, thereby helping to spread viral infection. Here
we have shown for the first time that activated NK cells stimulate
HIV-1 replication in DCs and thus might contribute to the
establishment of viral reservoirs in these cells. We demonstrated
the NK-cell activating capacity of HIV-1-infected iDCs and the
crucial involvement of HMGB1, produced during aNK-iDC
cross-talk, in the stimulation of HIV-1 replication and proviral
DNA expression in DCs. We also showed a strong impairment of
mature infected DCs to induce Th1 polarization following their
cross-talk with NK cells. Our observations reveal novel HIV
strategies to promote efficiently viral dissemination and escape the
immune system.
Interaction of NK cells with autologous iDCs results in
reciprocal activation, and this interaction seems crucial in the
initiation/amplification of the early phases of an immune
response, before T cells are generated [11]. NK cells trigger iDCs
to mature, and this occurs through an HMGB1-dependent
mechanism [20]. NK-dependent maturation of iDCs was reported
to involve a functional polarization of DCs, with increase in
intracellular free Ca
2+ concentration, cytoskeleton rearrangement,
accumulation of secretory lysosomes at the NK/DC synapse, and
regulated expression of IL-18 toward the interacting NK cells. In
turn, NK cells secrete large amounts of HMGB1, which induces
maturation of DCs [20]. Here, we confirm the involvement of
HMGB1 in NK-dependent DC maturation during NK-DC
contact, as shown by the inhibitory effect of anti-HMGB1
antibodies or glycyrrhizin, known to interact specifically with
HMGB1 [32]. Confocal microscopy analyses and HMGB1
detection in cell-free culture supernatants demonstrated that
HMGB1 was not only expressed and secreted by primary NK
cells, as reported [20], but it was also produced by isolated DCs,
the level of HMGB1 release being linked to their maturation stage.
An extremely high level of HMGB1 was detected when iDCs
where put in contact with aNK cells, similar to the one released by
mature DCs. Interestingly, confocal microscopy analysis of NK-
DC conjugates showed that both cells expressed the cytokine.
HMGB1 receptor, RAGE, was found rapidly induced following
DC interaction with aNK cells, and was further down-regulated,
compatible with the implication of HMGB1 in NK-dependent DC
maturation. In addition to contributing to DC maturation,
HMGB1 has been shown to act as a chemoattractant on iDCs
[46], and to be also required for migration of mature DCs in
response to CCR7 and CCR4 ligands [47], both activities being
mediated by RAGE [46,47]. Thus HMGB1 acts as an alarmin,
having activating and chemotactic effects on DCs, and stimulating
then the migration of DCs from inflamed tissues to the draining
lymph nodes [46]. These properties of HMGB1 have to be taken
into consideration in the context of an uncontrolled viral infection,
such as that induced by HIV.
Productive infection of iDCs with R5 or X4 strains of HIV-1
preserved NK-dependent phenotypic DC maturation, as shown by
the frequency of CD86
brightHLA-DR
bright DCs, while HIV itself
didn’t induce DC maturation in the range of p24 concentrations
used (0.001 to 10 ng/ml). However, the consequence of aNK-DC
interaction was a significant enhancement of HIV-1 infection in
iDCs. This was shown by several means, indicating an increased
frequency of p24
+ DC, associated with a significant enhancement
of p24 release in NK-DC culture supernatant, and this was
confirmed by immunofluorescence at the single cell level.
Moreover, NK-DC cross-talk resulted in a dramatic increase in
HIV-1 DNA expression in DCs. Considering the crucial role of
HMGB1 during the reciprocal activation of DCs and NK cells, we
evaluated its contribution to the triggering of HIV-1 replication in
iDCs with blocking anti-HMGB1 antibodies or glycyrrhizin. The
strong blocking effect of these inhibitors on p24 release indicates
the involvement of HMGB1 in the process. It is noteworthy that
both inhibitors also decreased significantly HIV-1 replication in
24 h cultures of infected iDCs, in the absence of NK cells. This is
cocultured for 21 h with aNK cells (aNK:iDC ratio 1:5). HMGB1 concentration was then measured in culture supernatants. Data represent the
mean6sd of three independent experiments. (e) Immunofluorescence confocal analysis of HMGB1expression in uninfected or HIV-1-infected iDCs.
Upper panel: non infected iDCs; middle panel: HIV-1-infected and replicating iDCs, as shown by intracellular p24 staining; lower panel: iDCs incubated
with HIV-1 but negative for intracellular p24 expression. (f) Mature DCs were generated by 48 h stimulation of iDCs with LPS (DC0), soluble CD40L
(DC1) or LPS+PGE2 (DC2). DC0, DC1 and DC2 were incubated for 3 h in medium or infected with HIV-1BaL (1 ng/ml of p24) and further incubated in
medium for 21 h. HMGB1 quantification in culture supernatants was performed. The mean6sd of three independent experiments is shown. (g)
Immunofluorescence analysis of HMGB1 expression in conjugates of aNK cells and uninfected (upper panel) or HIV-1-infected DCs (lower panel) in a
24 h coculture. DCs are DC-SIGN
+ and both aNK cells and DCs express HMGB1 in these conjugates. Pictures from one representative experiment out
of three conducted with different primary cell preparations are shown.
doi:10.1371/journal.pone.0003601.g002
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PLoS ONE | www.plosone.org 6 October 2008 | Volume 3 | Issue 10 | e3601Figure 3. aNK-dependent maturation of HIV-1-infected iDCs is mediated by HMGB1 and involoves RAGE. (a) Left panel: iDCs were
cultured for 24 h either alone or with aNK cells, in the presence of blocking anti-HMGB1 antibodies (10 mg/ml) or glycyrrhizin (10 mg/ml). The
maturation status of DCs was determined by flow cytometry with CD86 and HLA-DR –specific antibodies. Right panel: same experiment, but
performed with HIV-1 infected iDCs. Data represent mean6sd of at least three independent experiments, and statistical comparisons were made with
the non-parametric Mann-Whitney test. * p,0.05. (b) iDC (10
6 cells/ml) were cultured for 48 h with increasing concentrations (1–10 mg/ml) of rh-
HMGB1. Cells were then stained with anti-CD86, -HLA-DR, -CD80, -CD83, DC-LAMP and -CD40 antibodies and analysed by flow cytometry. (c)
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PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3601likely due to the spontaneous release of HMGB1 by iDC, shown
here and previously reported [47], which was preserved following
their infection with HIV-1. These observations reveal a pivotal
role for HMGB1 in controlling HIV-1 replication in DCs. As a
corollary, we demonstrated that rh-HMGB1 significantly in-
creased p24 release in culture supernatants of infected DCs and of
aNK-infected DC cocultures. These data may have important
implications in the understanding of HIV pathogenesis, since
plasma HMGB1 levels were found elevated in chronically HIV-1-
infected patients, with the highest concentrations in patients with
clinical complications [48]. Moreover, exogenous HMGB1 was
reported to induce in vitro the reactivation of HIV-1 in PBMCs
from HIV-1-infected patients under antiretroviral therapy [40].
Secreted HMGB1 is necessary for proliferation, survival, and
polarization of naı ¨ve CD4 T cells after activation by allogeneic
DCs, and these effects involve RAGE expressed by DCs [49].
Here, we show that, in syngeneic conditions, HMGB1 was not
able by itself to induce Th1 polarization. Indeed, no Th1 response
was induced in the presence of HIV-1-infected DCs, though they
continued to produce normal levels of HMGB1, while being
inhibited in the release of IL-12 and IL-18. Recent studies
highlighted the essential role of NK cells in the modulation of Th1
polarization, suggesting that they trigger IL-12 and IL-18 release
by DCs, promoting the production of IFN-c by NK cells that in
turn trigger the differentiation of T cells towards Th1 cells [50,51].
The essential role of IL-12 and IL-18 on Th1 differentiation is
confirmed here, since the defect of HIV-1 infected DCs to produce
increased amount of IL-12 and IL-18 in response to NK cell
activation was associated with a defective Th1 polarization. This
defect was directly linked to HIV-1 replication in DCs, as shown
by the positive effect of the HIV inhibitor AZT. These
observations suggest that some of the functional alterations
reported in DCs from HIV-infected patients [52,53], such as a
decreased secretion of several cytokines, including IL-12, and an
impaired ability to prime autologous CD4 T cells, may be linked
to a defective NK-DC cross-talk, as suggested recently [30].
Alteration of NK:DC cross may also lead to a defect in NK-cell
elimination of iDCs, as reported in chronically HIV-infected
patients [30] and associated with the resistance of HIV-infected
DCs to apoptosis induced by NK cells (Melki MT, Saı ¨di H,
Gougeon ML, submitted to publication).
In summary, we have shown that activation of HIV-1
replication and the possible establishment of viral reservoirs in
HIV-1-infected DCs is dependent on a cross-talk between aNK
cells and autologous DCs. We have identified the pivotal role of
HMGB1 in this process, produced both by NK cells and DCs
during their cross-talk, and showed that NK-dependent triggering
of HIV replication in DCs is completely abrogated by Glycyrrhi-
zin, which binds specifically to HMGB1, or blocking anti-HMGB1
antibodies. In addition, our data indicate a strong impairment of
HIV-1-infected DCs to induce Th1 polarization following their
cross-talk with NK cells. These observations provide evidence of
the crucial role of NK-DC cross-talk in promoting viral
dissemination, and challenges the question of the in vivo
involvement of HMGB1 in the triggering of viral replication and
replenishment of viral reservoirs.
Methods
Isolation and separation of primary cells
Peripheral blood mononuclear cells (PBMCs) were separated
from the blood of healthy donors on a Ficoll-Hypaque density
gradient. PBMC were obtained through the French blood bank
(Etablissement Franc ¸ais du Sang, Paris, France) in the setting of
EFS-Institut Pasteur Convention. A written agreement was
obtained for each donor to use the cells for clinical research
according to French laws. Our study was approved by IRB,
external (Etablissement Franc ¸ais du Sang Board) as required by
French law and internal (Biomedical Research Committee Board,
Institut Pasteur) as required by Pasteur Institute.
We isolated CD14
+ monocytes from PBMCs by positive
selection using CD14-specific immunomagnetic beads (Miltenyi
Biotech, Auburn, CA). To generate iDCs, purified CD14
+
monocytes were cultured for 5 days (1610
6 cells/ml) in RPMI
1640 medium supplemented with 2 mM glutamine, 10% FCS,
penicillin (100 U/ml) and streptomycin (100 mg/ml), in the
presence of 10 ng/ml of recombinant human (rhu) GM-CSF
and 10 ng/ml rhIL-4 (Peprotech INC, Rockyhill, USA) as
described [54]. Culture medium was replaced every 2 days. NK
cells were isolated by negative selection from PBMCs depleted of
monocytes using a depletion cocktail of antibodies directed to
CD3, CD4, CD14, CD19, CD20, CD36, CD123, CD66b,
Glycophorin A (StemCell Technologies). The NK cell content of
the enriched fraction, determined by flow cytometry (FACScali-
bur, Becton Dickinson) as CD3
2CD56
+ cells with FITC-
conjugated anti-CD3 and APC-conjugated anti-CD56 antibodies,
ranged from 85 to 95% in the different experiments. Contami-
nation with myeloid cells, evaluated with FITC-conjugated anti-
CD14 antibodies was consistently less than 1%. Naı ¨ve CD4 T cells
(CD4
+CD45RA
+) were isolated from PBMCs by positive selection,
using CD4- and CD45RA-specific immunomagnetic beads
(Miltenyi Biotech, Auburn, CA). Cell purity of isolated naı ¨ve
CD4 T cells was routinely more than 90%.
Activation and infection of NK cells
Purified NK cells were cultured at 10
6 cells/ml either in the
presence of suboptimal concentration of IL-2 (100 ng/ml)
(Peprotech) to maintain them alive (referred as rNK) or were
activated by a combination of PHA (10 mg/ml) (Sigma) and IL-2
(10 mg/ml) (referred as aNK cells). In some experiments, aNK
cells (10
6 cells/ml) were incubated during 3 h in the presence of
HIV-1 (1 ng/ml p24) and further cultured for 21 h. Under those
conditions, no productive infection could be observed. Culture
supernatants were then tested for cytokine and chemokine
detection (see below).
Maturation and phenotypic analysis of DCs
After 6 days of culture in the presence of IL-4 and GM-CSF,
iDCs (10
6 cells/ml) were either non stimulated, or stimulated
during 48 h with 10 mg/ml LPS (E. Coli serotype 026-B6, Sigma-
Aldrich) to obtain DC0 cells, or 500 ng/ml of trimeric CD40L
(Sigma-Aldrich) to obtain DC1 cells, or 10 mg/ml of LPS and
1 mg/ml PGE2 (Sigma-Aldrich) to obtain DC2 cells. Phenotypic
Influence of rh-HMGB1 on cytokine and chemokine production (determined by MAP) by DCs. iDCs (10
6 cells/ml) were incubated for 48 h in medium
or in presence of rh-HMGB1 (1 or 10 mg/ml). As a positive control, iDCs were stimulated with LPS (DC0). (d) Flow cytometry detection of surface
expression of RAGE by iDCs, DC0, or iDCs incubated with rh-HMGB1 (1 mg/ml). iDCs were either non infected or infected with HIV-1BaL (1 ng/ml p24
for 3 h). (e) iDC, DC0, uninfected or HIV-1-infected iDC cocultured for 24 h with aNK cells, were incubated with rh-HMGB1 (1 mg/ml) and
subsequently stained with anti-RAGE antibodies and analyzed by flow cytometry. NK cells were excluded from the analysis through the co-staining
with CD3- and CD56-specific antibodies (CD3
2CD56
+).
doi:10.1371/journal.pone.0003601.g003
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PLoS ONE | www.plosone.org 8 October 2008 | Volume 3 | Issue 10 | e3601Figure 4. Impairment of NK-triggered Th1 polarization by DCs following HIV-1 infection is associated to altered IL-12 and IL-18
production. (a) Th1 polarization by DCs triggered by NK cells was tested by incubating iDC (10
6/ml) for 30 mn in the presence of rNK or aNK cells
(2610
5/ml). Naı ¨ve CD4 T cells (10
6/ml) were added to the cocultures and the frequency of T cells producing IFN-c or IL-4 was determined by flow
cytometry 8 days later. The experiment was performed with either uninfected iDCs (b) iDCs infected with HIV-1BaL (c), or iDC infected with HIV-1BaL in
the presence of AZT (1 mM) (d). Culture supernatants of indicated cultures were tested for IL-12 (e), IL-18 (f), and IFN-g (g) content. Data represent
the mean6sd of five independent experiments. Statistical comparisons were made with the non-parametric Mann-Whitney test. * p,0.05, **p=0.03.
doi:10.1371/journal.pone.0003601.g004
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PLoS ONE | www.plosone.org 9 October 2008 | Volume 3 | Issue 10 | e3601analysis of DCs and characterization of their maturation stage was
performed by flow cytometry. DCs were stained for 20 min at 4uC
with antibodies specific for CD80, CD83, CD86, HLA-DR,
CD40, DC-LAMP or DC-SIGN (all antibodies from BD
Biosciences, San Jose, CA) diluted in 100 ml of PBS/10% FCS/
0.1% NaN
3. In some experiments, antibodies specific for
HMGB1-receptor, RAGE (Abcam, Cambridge, UK), was used
to stain DCs. After two washings, cells were fixed in 1% PFA,
immediately acquired on a FACScalibur (Becton Dickinson) and
analyzed with Flow Jo software.
Figure 5. HMGB1-dependent triggering of HIV replication in DC as a consequence of NK-DC cross talk. (a) Flow cytometry analysis of
p24 intracellular expression in iDCs (CD40
+), either uninfected (upper panel) or infected with HIV-1BaL (lower panel) following 3 day-incubation at 10
6/
ml, either alone, or in the presence of rNK or aNK cells (2610
5/ml). (b) p24 concentration in culture supernatants of same cultures. Mean6sd of three
independent experiments. *p,0.05, non-parametric Mann-Whitney test. (c) Immunofluorescence analysis of intracellular p24 expression in HIV-1-
infected iDCs cultured for 3 days either alone or in the presence of aNK cells. Nuclei are stained with DAPI. (d) Flow cytometry intracellular p24
expression in HIV-1-infected DC0 (10
6/ml) cultured either alone or in the presence of aNK cells for 6 days. (e) HIV-1 proviral DNA levels, determined by
light cycler analysis on cells from indicated cultures. One representative experiment out of three conducted with different primary cells preparations
is shown. (f) p24 concentration in culture supernatants of mature DCs infected with HIV-1BaL and cultured for 6 days either alone or in the presence
of rNK or aNK cells Mean6sd of three independent experiments. Statistical comparisons were made with the non-parametric Mann-Whitney test.
*p ,0.05, **p=0.03. (g) p24 concentration in culture supernatants of either iDCs or mature DCs infected with HIV-1NDK and cultured under the same
conditions as in (f). Mean6sd of three independent experiments. Statistical comparisons were made with the non-parametric Mann-Whitney test.
*p ,0.05.
doi:10.1371/journal.pone.0003601.g005
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Virus stock preparation was prepared by amplification of R5-
HIV-1BaL and X4- HIV-1NDK on MDM and PHA+ IL-2
activated PBMC from healthy donors, respectively. Viral stock
was then clarified by centrifugation prior to determination of
HIV-1 p24 concentration. iDCs were plated in 96-well culture
plates at 200,000 cells/well and incubated for 3 hours at 37uCi na
5% CO2 atmosphere with HIV-1 at various concentrations (0.001
to 10 ng p24/ml). Cells were harvested, washed four times with
media containing 10% FCS and, when indicated, rNK or aNK
cells were added at a NK:DC ratio of 1:5, unless otherwise
indicated. NK-DC cocultures lasted 24 h before analysis of the
maturation stage of DCs and/or quantification of viral production.
In some experiments (Fig. 6), HIV-1 infected iDCs were
incubated alone or with aNK cells for 3 days, in the presence of
rh-HMGB1 (1 mg/ml) (R&DSystems), rabbit anti-HMGB1 Abs
(10 mg/ml) (Abcam, Cambridge, UK) or Glycyrrhizin (10 mg/ml).
Quantification of HIV-1 viral production, proviral load and
of the frequency of infected DCs
We determined the concentration of HIV-1 in the supernatant
of infected cell cultures by measuring the amount of p24 protein
by ELISA (Ingen, Belgium). We extracted DNA from cells using
the GIAamp DNA Blood Mini Kit (Qiagen, Basel, Switzerland)
and quantified HIV-1 proviral load by RT-PCR as described
previously [55]. The frequency of HIV-1-infected cells was
determined by flow cytometry to detect intracellular p24 molecule.
Cells were surface stained with antibodies specific for CD40 (BD
Biosciences, San Jose, CA) to target DC and intracellular stained
with p24-specific antibodies (Coulter). Stained cells were fixed in
1% PFA, immediately acquired on a FACScalibur (Becton
Dickinson) and analyzed with FlowJo software. In some experi-
ments infected DCs were imaged, after immunofluorescence, by
laser scanning confocal microscopy.
Cocultures of iDCs with NK cells
rNK or aNK were cocultured during 24 h with iDCs or mDCs
at a ratio of 1:5 (2610
5 NK+10610
5 DC/ml), unless otherwise
indicated. DC survival was determined with the 7-AAD assay, as
described previously [56]. Briefly, cultured cells were stained with
20 mg/mL nuclear dye 7-amino-actinomycin D (7-AAD; St.
Quentin-Fallavier, Sigma-Aldrich) for 30 minutes at 4uC, and
co-stained with CD56-specific antibody (BD Biosciences, San jose,
CA). Surviving DC were identified as CD56
2 7-AAD
2 cells.
When phenotypic characterization of DCs was performed in NK-
DC cocultures, NK cells were always excluded from the FACS
analysis through their staining with CD56-specific antibodies.
Measurement of cytokine and chemokine production
Cell-free culture supernatants were prepared by incubating for
24 h iDCs at 10
6 cells/ml, rNK or aNK cells at 2.10
5 cells/ml or
aNK and iDC cells at the ration of 1:5. Chemokines and cytokines
were measured by Luminex (24 plex kits; Biosource) following the
manufacturer’s instructions. In brief, 50 ml of supernatant or
standard was incubated with antibody-linked beads for 2 h,
washed twice with wash solution, and incubated for 1 h with
biotinylated secondary antibodies. A final incubation of 30 min
with streptavidin-PE preceded the acquisition on the Luminex
100IS. At least 100 events were acquired for each analyte. Values
above or below the standard curves were replaced by the lowest or
the highest concentrations measured. Quantification of HMGB1in
cell free culture supernatants was performed with an ELISA kit
(IBL, Hamburg). In experiments testing Th1 polarization of naı ¨ve
CD4 T cells by NK-triggered DCs (Figure 4), quantification of IL-
12, IFN-c and IL-18 in culture supernatants was performed with
ELISA kits (IL-12 and IFN-c kits from R&D Systems, IL-18 kit
from MBL).
Th1 polarization assay
Naı ¨ve CD4 T cells (10
6/ml) were cocultured for 8 days in the
presence of uninfected or HIV-1-infected iDC (10
6/ml) and
resting or activated NK cells (2610
5/ml) and tested for Th1
polarization by flow cytometry, as previously reported [57].
Briefly, brefeldine A (10 mg/ml) (Sigma Aldrich) was added
during the last 16 h of the culture to inhibit protein secretion.
Surface staining was performed with PerCP-conjugated CD8
antibodies and FITC-conjugated CD3 antibodies (BD Bioscienc-
es, San Jose, CA), followed by cell fixation for 15 minutes at 4uC
with 1% PFA and permeabilization with saponin buffer (PBS-
BSA 0.2%-NaN
3 0.01%- saponin 0.5%), and intracellular
staining was performed with APC-conjugated IFNc ˜- or IL-4-
specific antibodies (BD Biosciences, San Jose, CA). Stained cells
were immediately acquired on a FACScalibur (Becton Dickinson)
and analyzed with Flow Jo software. In order to analyze the
influence of HIV-1 replication on Th1 polarization, AZT 1 mM
was added at the initiation of the culture of naı ¨ve CD4 T cells
incubated alone, or in the presence of HIV-1-infected iDCs+/
2rNK or aNK cells. AZT was left until the end of the coculture.
HIV-1-infection of iDCs was performed as described above, in
the absence of AZT.
Figure 6. Exogenous rh-HMGB1 triggers HIV-1 replication in iDC. (a) iDC -infected with HIV-1BaL were cultured either alone or in the
presence of aNK cells for 3 days. rh-HMGB1 (1 mg/ml) was added in some cultures. HIV replication was measured by p24 quantification in culture
supernatant. (b) HIV-1-infected iDC were cultured either alone or in the presence of aNK cells for 3 days. Blocking anti-HMGB1 antibodies (10 mg/ml)
or glycyrrhizin (10 mg/ml) were added at culture initiation. HIV replication was measured by p24 quantification in culture supernatant. The mean6sd
of three independent experiments is shown. Statistical comparisons were made with the non-parametric Mann-Whitney test. * p,0.05.
doi:10.1371/journal.pone.0003601.g006
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Statistical analyses were made with the non-parametric Mann-
Whitney test. The P value of significant differences is reported.
Plotted data represent mean6standard deviation (s.d.).
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